Xention

Manufacturing · United Kingdom · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Unit 3 Iconix Park London Rd, Sawston, C...

Phone Number

+44 1223493900

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Xention

Xention is a leader in the discovery and development of ion channel-modulating drugs. The Company is developing a pipeline of innovative products for the treatment of atrial fibrillation, an indication for which there is high unmet medical need, by targeting key ion channels. Xention uses an innovative approach to discover and design potent and selective small-molecule drugs and has collaborations with several companies. In atrial fibrillation, the company is developing modulators of Kv1.5 and Kir3.1/3.4 (IKACh), both recognised as novel, highly exciting new targets for the disease. Its Kv1.5 programme is the subject of a partnership with Servier for all territories except the US and Japan.Explore more
Xention's Social MediaPopular SearchesXENTION LtdXentionXention DiscoveryXention Pharma LtdSIC Code 28,283NAICS Code 32,325Show more

Is Xention your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Xention

Compare insights from companies similar to Xention, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Xention

<$5M
11-50
Private
$44.9M
2001
N/A
$8M
11-50
Private
-
1992
N/A
$6.7M
11-50
Private
$14.2M
2015
CM
Christopher MathesGeneral Manager (North America)
$6.3M
11-50
Private
-
1990
$5.9M
11-50
Private
-
1994
N/A
$5.2M
11-50
Private
-
2002
N/A
<$5M
11-50
Private
-
2015
AW
Andrew WinkleySenior Toxicologist
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Xention is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Xention is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xention.

Xention financials insights

Gather financial insights about Xention, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2003

Series A

$5.7M

Series C

$6.5M

2005

Series B

$20M

2010

Series D

$12.7M

See All Xention's Financials Insights

Xention Tech Stack

A closer look at the technologies used by Xention

Top Manufacturing Companies

Frequently Asked Questions Regarding Xention

What is Xention's official website?
Xention's official website is www.xention.com
What is Xention's Revenue?
Xention's revenue is <$5 Million
What is Xention's SIC code?
Xention's SIC: 28,283
What is Xention's NAICS code?
Xention's NAICS: 32,325
How many employees does Xention have?
Xention has 11-50 employees
What industry does Xention belong to?
Xention is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Xention competition?
Xention top competitors include: Metrion Biosciences, Aurora Biomed, Scottish Biomedical, apconix
What technology does Xention use?
Some of the popular technologies that Xention uses are: Microsoft 365, Microsoft Exchange Online
How do I contact Xention?
Xention contact info: Phone number: +44 1223493900 Website: www.xention.com
What does Xention do?

Xention is a leader in the discovery and development of ion channel-modulating drugs. The Company is developing a pipeline of innovative products for the treatment of atrial fibrillation, an indication for which there is high unmet medical need, by targeting key ion channels. Xention uses an innovative approach to discover and design potent and sel... ective small-molecule drugs and has collaborations with several companies. In atrial fibrillation, the company is developing modulators of Kv1.5 and Kir3.1/3.4 (IKACh), both recognised as novel, highly exciting new targets for the disease. Its Kv1.5 programme is the subject of a partnership with Servier for all territories except the US and Japan.Read More

What are Xention social media links?
Xention Linkedin page
Who invested in Xention?
Xention has 15 investors including MVM Life Science Partners, BTG, SPARK Ventures and Albany Ventures.
Is Xention a public company?
Xention is private company therefore does not currently have an official ticker symbol
See more information about Xention

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.